-
Loading metrics
Open Access
Peer-reviewed
Research Article
Analysis of the 10q11 Cancer Risk Locus Implicates MSMB and NCOA4 in Human Prostate Tumorigenesis
-
Mark M. Pomerantz ,
Contributed equally to this work with: Mark M. Pomerantz, Yashaswi Shrestha
Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
Yashaswi Shrestha ,
Contributed equally to this work with: Mark M. Pomerantz, Yashaswi Shrestha
Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America
⨯ -
Richard J. Flavin,
Affiliation Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts, United States of America
⨯ -
Meredith M. Regan,
Affiliation Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
Kathryn L. Penney,
Affiliation Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America
⨯ -
Lorelei A. Mucci,
Affiliations Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
Meir J. Stampfer,
Affiliations Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America, Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, United States of America
⨯ -
David J. Hunter,
Affiliations Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America, Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, United States of America
⨯ -
Stephen J. Chanock,
Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Eric J. Schafer,
Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America
⨯ -
Jennifer A. Chan,
Affiliation Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada
⨯ -
Josep Tabernero,
Affiliation Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain
⨯ -
José Baselga,
Affiliation Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain
⨯ -
Andrea L. Richardson,
Affiliation Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
Massimo Loda,
Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
William K. Oh,
Affiliation Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York, United States of America
⨯ -
Philip W. Kantoff,
Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
William C. Hahn,
Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America, Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America
⨯ - [ ... ],
-
Matthew L. Freedman
* E-mail: freedman@broadinstitute.org
Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America
⨯ - [ view all ]
- [ view less ]
Analysis of the 10q11 Cancer Risk Locus Implicates MSMB and NCOA4 in Human Prostate Tumorigenesis
- Mark M. Pomerantz,
- Yashaswi Shrestha,
- Richard J. Flavin,
- Meredith M. Regan,
- Kathryn L. Penney,
- Lorelei A. Mucci,
- Meir J. Stampfer,
- David J. Hunter,
- Stephen J. Chanock,
- Eric J. Schafer
- Published: November 11, 2010
- https://doi.org/10.1371/journal.pgen.1001204